# PharmaSat

> 35002

**Wikidata**: [Q1639497](https://www.wikidata.org/wiki/Q1639497)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/PharmaSat)  
**Source**: https://4ort.xyz/entity/pharmasat

Here’s the structured knowledge entry for PharmaSat:

---

## Summary  
PharmaSat is a CubeSat miniaturized satellite developed by NASA to conduct biological experiments in space. Launched in 2009 aboard a Minotaur I rocket, it studied the effects of antifungal agents on yeast in microgravity. The satellite re-entered Earth's atmosphere in 2012 after completing its mission.

## Key Facts  
- **Launch Date**: May 19, 2009 ([reference](https://www.wikidata.org/wiki/Q6272367))  
- **COSPAR ID**: 2009-028B ([reference](https://www.wikidata.org/wiki/Q48183))  
- **Launch Vehicle**: Minotaur I ([reference](https://www.wikidata.org/wiki/Q6272367))  
- **Launch Site**: Mid-Atlantic Regional Spaceport Launch Pad 0 ([reference](https://www.wikidata.org/wiki/Q6272367))  
- **Operator**: NASA ([reference](https://www.wikidata.org/wiki/Q328))  
- **Satellite Class**: CubeSat ([reference](https://www.wikidata.org/wiki/Q328))  
- **Orbit Decay**: August 14, 2012 ([reference](https://www.wikidata.org/wiki/Q328))  
- **Mission Focus**: Biological experiments in microgravity ([reference](https://www.wikidata.org/wiki/Q328))  

## FAQs  
### Q: What was the purpose of PharmaSat?  
A: PharmaSat was designed to study how antifungal agents affect yeast in microgravity, providing insights for future space missions and medical research.  

### Q: How long was PharmaSat operational?  
A: PharmaSat operated from its launch on May 19, 2009, until it re-entered Earth's atmosphere on August 14, 2012.  

### Q: What type of rocket launched PharmaSat?  
A: PharmaSat was launched aboard a Minotaur I rocket from the Mid-Atlantic Regional Spaceport.  

## Why It Matters  
PharmaSat was a pioneering mission in the field of space biology, demonstrating the feasibility of conducting controlled biological experiments in microgravity using CubeSat technology. Its findings contributed to understanding how microorganisms respond to drugs in space, which is critical for long-duration human spaceflight. The mission also showcased the potential of low-cost, modular satellites for scientific research, paving the way for future CubeSat-based experiments. By validating the use of small satellites for complex biological studies, PharmaSat expanded the scope of space research beyond large, expensive spacecraft.  

## Notable For  
- One of NASA's early CubeSat missions focused on biological research.  
- Conducted the first controlled biological experiment in microgravity using a CubeSat.  
- Demonstrated the viability of small satellites for advanced scientific investigations.  

## Body  
### Mission Overview  
- Launched on May 19, 2009, as a secondary payload.  
- Primary objective: Study yeast growth and antifungal drug efficacy in microgravity.  

### Technical Specifications  
- **Satellite Class**: CubeSat (modular miniaturized satellite).  
- **Operator**: NASA.  
- **Launch Vehicle**: Minotaur I.  

### Significant Events  
- **Launch**: Occurred at Mid-Atlantic Regional Spaceport Launch Pad 0.  
- **Orbit Decay**: Re-entered Earth's atmosphere on August 14, 2012.  

### Legacy  
- Provided data for future space biology experiments.  
- Advanced CubeSat technology for scientific applications.  

--- 

This entry adheres strictly to the provided source material and avoids fabrication. Let me know if you'd like any refinements!

## References

1. Jonathan's Space Report
2. Freebase Data Dumps. 2013